Patents by Inventor Kohki Tsukamoto

Kohki Tsukamoto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8138335
    Abstract: A compound represented by formula (I) wherein the symbols in the formula are the same meanings as those in specification, salts thereof, solvates thereof, or prodrugs thereof binds to DP receptor and shows antagonistic activity for DP receptor. Thus, it is useful for prevention and/or treatment of diseases such as allergic disease (e.g., allergic rhinitis, allergic conjunctivitis, atopic dermatitis, bronchial asthma and food allergy), systemic mastocytosis, disorders accompanied by systemic mast cell activation, anaphylaxis shock, bronchoconstriction, urticaria, eczema, diseases accompanied by itch (e.g., atopic dermatitis and urticaria), diseases (e.g., cataract, retinal detachment, inflammation, infection and sleeping disorders) which is generated secondarily as a result of behavior accompanied by itch (e.g.
    Type: Grant
    Filed: September 1, 2009
    Date of Patent: March 20, 2012
    Assignee: Ono Pharmaceutical Co., Ltd
    Inventors: Atsushi Naganawa, Maki Iwahashi, Atsushi Kinoshita, Atsushi Shimabukuro, Seiji Ogawa, Koji Yano, Kaoru Kobayashi, Yutaka Okada, Yoko Kishida, Shouji Kawauchi, Kohki Tsukamoto, Yoko Matsunaga, Fumio Nambu
  • Publication number: 20100029631
    Abstract: A compound represented by formula (I) wherein the symbols in the formula are the same meanings as those in specification, salts thereof, solvates thereof, or prodrugs thereof binds to DP receptor and shows antagonistic activity for DP receptor. Thus, it is useful for prevention and/or treatment of diseases such as allergic disease (e.g., allergic rhinitis, allergic conjunctivitis, atopic dermatitis, bronchial asthma and food allergy), systemic mastocytosis, disorders accompanied by systemic mast cell activation, anaphylaxis shock, bronchoconstriction, urticaria, eczema, diseases accompanied by itch (e.g., atopic dermatitis and urticaria), diseases (e.g., cataract, retinal detachment, inflammation, infection and sleeping disorders) which is generated secondarily as a result of behavior accompanied by itch (e.g.
    Type: Application
    Filed: September 1, 2009
    Publication date: February 4, 2010
    Applicant: ONO Pharmaceutical Co., Ltd.
    Inventors: Atsushi Naganawa, Maki Iwahashi, Atsushi Kinoshita, Atsushi Shimabukuro, Seiji Ogawa, Koji Yano, Kaoru Kobayashi, Yutaka Okada, Yoko Kishida, Shouji Kawauchi, Kohki Tsukamoto, Yoko Matsunaga, Fumio Nambu
  • Patent number: 7601712
    Abstract: A compound represented by formula (I) wherein the symbols in the formula are the same meanings as those in specification, salts thereof, solvates thereof, or prodrugs thereof binds to DP receptor and shows antagonistic activity for DP receptor. Thus, it is useful for prevention and/or treatment of diseases such as allergic disease (e.g., allergic rhinitis, allergic conjunctivitis, atopic dermatitis, bronchial asthma and food allergy), systemic mastocytosis, disorders accompanied by systemic mast cell activation, anaphylaxis shock, bronchoconstriction, urticaria, eczema, diseases accompanied by itch (e.g., atopic dermatitis and urticaria), diseases (e.g., cataract, retinal detachment, inflammation, infection and sleeping disorders) which is generated secondarily as a result of behavior accompanied by itch (e.g.
    Type: Grant
    Filed: September 16, 2004
    Date of Patent: October 13, 2009
    Assignee: Ono Pharmaceutical Co., Ltd.
    Inventors: Atsushi Naganawa, Maki Iwahashi, Atsushi Kinoshita, Atsushi Shimabukuro, Seiji Ogawa, Koji Yano, Kaoru Kobayashi, Yutaka Okada, Yoko Kishida, Shouji Kawauchi, Kohki Tsukamoto, Yoko Matsunaga, Fumio Nambu
  • Publication number: 20070004716
    Abstract: A compound represented by formula (I) wherein the symbols in the formula are the same meanings as those in specification, salts thereof, solvates thereof, or prodrugs thereof binds to DP receptor and shows antagonistic activity for DP receptor. Thus, it is useful for prevention and/or treatment of diseases such as allergic disease (e.g., allergic rhinitis, allergic conjunctivitis, atopic dermatitis, bronchial asthma and food allergy), systemic mastocytosis, disorders accompanied by systemic mast cell activation, anaphylaxis shock, bronchoconstriction, urticaria, eczema, diseases accompanied by itch (e.g., atopic dermatitis and urticaria), diseases (e.g., cataract, retinal detachment, inflammation, infection and sleeping disorders) which is generated secondarily as a result of behavior accompanied by itch (e.g.
    Type: Application
    Filed: September 16, 2004
    Publication date: January 4, 2007
    Inventors: Atsushi Naganawa, Maki Iwahashi, Atsushi Kinoshita, Atsushi Shimabukuro, SeijiKoji Ogawa, Koji Yano, Kaoru Kobayashi, Yutaka Okada, Yoko Kishida, Shouji Kawauchi, Kohki Tsukamoto, Yoko Matsunaga, Fumio Nambu